A Novel Rehabilitation Approach: Dyadic Strategy Training for Stroke Survivors and Their Caregivers

Launched by TAIPEI MEDICAL UNIVERSITY · Oct 5, 2022

Keywords

ClinConnect Summary

This clinical trial is studying a new rehabilitation program designed for stroke survivors and their caregivers. The goal is to see if this program, which focuses on both the survivor and their caregiver working together, can improve their ability to participate in daily activities. The researchers will compare this new approach to standard care to find out if it really makes a difference. They plan to recruit about 138 pairs of stroke survivors and their caregivers from hospitals in Northern Taiwan.

To join the study, stroke survivors must be at least 20 years old, have had their first stroke within the last two years, and have a primary caregiver who helps them. Both the survivor and caregiver need to be able to speak Mandarin and provide consent to participate. Participants will take part in training sessions and share their experiences in interviews after the program. This research aims to provide valuable information on whether this new training can help improve the lives of stroke survivors and their caregivers, both in the short term and long term.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Stroke survivors
• • 1. ages 20 years and older;
• • 2. has been diagnosed with a first-time stroke within the past two year;
• • 3. speaks Mandarin;
• • 4. has an identified primary caregiver who provides care or assistance of any kind and taking responsibility for the survivor;
• • 5. is able to provide informed consent.
• • Family caregivers include that the caregiver
• • 1. ages 20 years and older;
• • 2. speaks Mandarin;
• • 3. is the primary caregiver recognized by the survivor;
• • 4. is available to participate in the intervention sessions with the survivor;
• • 5. is able to provide informed consent.
• Exclusion Criteria:
• * The survivor-caregiver dyad will be excluded if any of them:
• • 1. requires significant medical treatment (e.g., chemotherapy, radiation therapy, or hemo/peritoneal dialysis) that may impede them from participating in the study;
• • 2. has severe aphasia;
• • 3. is unable to participate in a 1-hour discussion session;
• • 4. has a diagnosis of dementia, major depressive disorder, substance use or other psychiatric disorders that may impede them from participating in the study.